Cannabis
Germany Postpones Again Vote on Cannabis Legalization
However, the process of legalizing cannabis in Germany has been met with resistance from many institutions, including doctors, judges, police, and medical organizations. This shows that the reform has its supporters, but also opponents. There are also plans for commercial sales programs in cities across the country, which will be revealed once the idea is approved by the European Commission.
Germany is not going to legalize cannabis this month. German lawmakers have decided to postpone the vote on cannabis legalization, which was originally scheduled to take place next week, before December 2023. The originally planned entry into force of the cannabis law on January 1st, 2024, will not happen. Experts predict that the bill will go into effect in March 2024.
Social Democratic Party (SPD) MP Carmen Wegge announced the delay, stressing the need for further work on the bill.
Read more about the postponing of cannabis legalization in Germany and find other important cannabis news from around the world with the Hemp.im mobile app, available for free for both Android and iOS devices.
This means that Germany will have to wait longer to legalize cannabis
“The decision on CannG will be made in December. This means that we are falling behind schedule. I know this is a huge disappointment for many. Therefore, this decision was not easy for anyone. However, well-designed improvements are in everyone’s interest.”
Kirsten Kappert-Gonther of the Green Party explained the delay as an opportunity to improve the bill. It is an attempt to ensure that the reform is implemented in a responsible and quality-focused manner.
The Bundesrat, the body representing the German states, will also have to adjust its actions to accommodate the delay in the Bundestag. This could affect the legislative timetable.
Despite the delay, some observers believe the reform may be introduced later than originally planned. This is generating mixed reactions in the public, with some feeling disappointment over the protracted process.
The bill calls for the legal possession of up to 25g of cannabis for personal use and the cultivation of up to 3 cannabis plants by adults, the creation of cannabis clubs, and a pilot program for commercial sales. It’s a comprehensive reform that will have a broad impact on national and European drug policy.
Coalition government leaders stress the need to educate the public about the dangers of cannabis use. They want to ensure that the legalization process in Germany will be accompanied by an educational campaign.
However, the process of legalizing cannabis in Germany has been met with resistance from many institutions, including doctors, judges, police, and medical organizations. This shows that the reform has its supporters, but also opponents.
There are also plans for commercial sales programs in cities across the country, which will be revealed once the idea is approved by the European Commission. This is the next step in the reform, which will affect the cannabis market in Germany.
Ultimately, the delay in the process of legalizing cannabis in Germany raises many questions about the future of drug policy and may affect when and how legalization will be implemented. This is a topic that will continue to be followed by the public and political observers.
—
(Featured image by Aron Marinelli via Unsplash)
DISCLAIMER: This article was written by a third-party contributor and does not reflect the opinion of Hemp.im, its management, staff, or its associates. Please review our disclaimer for more information.
This article may include forward-looking statements. These forward-looking statements generally are identified by the words “believe,” “project,” “estimate,” “become,” “plan,” “will,” and similar expressions. These forward-looking statements involve known and unknown risks as well as uncertainties, including those discussed in the following cautionary statements and elsewhere in this article and on this site. Although the company may believe that its expectations are based on reasonable assumptions, the actual results that the company may achieve may differ materially from any forward-looking statements, which reflect the opinions of the management of the company only as of the date hereof. Additionally, please make sure to read these important disclosures.
First published in FaktyKonopne, a third-party contributor translated and adapted the article from the original. In case of discrepancy, the original will prevail.
Although we made reasonable efforts to provide accurate translations, some parts may be incorrect. Hemp.im assumes no responsibility for errors, omissions or ambiguities in the translations provided on this website. Any person or entity relying on translated content does so at their own risk. Hemp.im is not responsible for losses caused by such reliance on the accuracy or reliability of translated information. If you wish to report an error or inaccuracy in the translation, we encourage you to contact us.
-
Crowdfunding1 week ago
Rendimento Etico Suspended by Consob for Irregularities and Conflicts of Interest
-
Fintech3 hours ago
Fintech Investments in Latin America Rise 73% Despite a Drop in the Number of Deals in 2024
-
Fintech1 week ago
Deutsche Bank Develops Layer 2 for Ethereum – With Extras for Authorities
-
Biotech2 weeks ago
Quirónsalud and Roche Farma Sign an Agreement to Promote Healthcare Innovation and Research